STOCK TITAN

SpyGlass Pharma holder proposes $1.17M share sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

SpyGlass Pharma, Inc. (SGP) shareholder Samsara BioCapital, L.P. reported a proposed sale of 37,166 common shares, with an approximate sale date of November 18, 2026 and an aggregate market value of $1,168,499.04. The shares were acquired from the issuer for cash in a private placement on July 6, 2023. Merrill Lynch is named as broker and Nasdaq as the exchange.

Common shares listed for sale 37,166 shares Samsara BioCapital, L.P.; approximate sale date November 18, 2026.
Aggregate market value $1,168,499.04 Value stated for the 37,166 common shares listed for sale.
Shares outstanding 33,461,450 shares Issuer share count stated in the securities information.
Private Placement financial
"acquired in a private placement on July 6, 2023"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SGP shares does Samsara BioCapital plan to sell, and what is their stated value?

Samsara BioCapital, L.P. lists 37,166 shares with an aggregate market value of $1,168,499.04 for an approximate sale date of November 18, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading